John Goll

2020

In 2020, John Goll earned a total compensation of $1M as Interim Principal Financial Officer at INSMED, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$151,000
Option Awards$375,013
Salary$345,050
Stock Awards$124,996
Other$17,318
Total$1,013,377

Goll received $375K in option awards, accounting for 37% of the total pay in 2020.

Goll also received $151K in non-equity incentive plan, $345.1K in salary, $125K in stock awards and $17.3K in other compensation.

Rankings

In 2020, John Goll's compensation ranked 8,582nd out of 13,090 executives tracked by ExecPay. In other words, Goll earned more than 34.4% of executives.

ClassificationRankingPercentile
All
8,582
out of 13,090
34th
Division
Manufacturing
3,654
out of 5,618
35th
Major group
Chemicals And Allied Products
1,478
out of 2,251
34th
Industry group
Drugs
1,286
out of 1,951
34th
Industry
Pharmaceutical Preparations
950
out of 1,456
35th
Source: SEC filing on April 1, 2021.

Goll's colleagues

We found five more compensation records of executives who worked with John Goll at INSMED in 2020.

2020

William Lewis

INSMED

Chief Executive Officer

2020

Martina Flammer

INSMED

Chief Medical Officer

2020

Roger Adsett

INSMED

Chief Operating Officer

2020

Christine Pellizzari

INSMED

Chief Legal Officer

2020

Sara Bonstein

INSMED

Chief Financial Officer

News

You may also like